NASDAQ NMS - GLOBAL MARKET · CV
-0.45% · -$0.0300 · Vol 58.0K
Market closed · last close 4:00 PM ET · price as of 16:01:35 ET
CapsoVision Inc

CapsoVision Inc

Health Care
$6.59
Card
Relationship Map

Follow $CV

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CV by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
CV
CapsoVision Inc
Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

60/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CV catalysts
About CapsoVision Inc
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed since
2025
Employees
99
Country
US

CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$6.62
Day high
$6.73
Day low
$6.54
Previous close
$6.62
52W high
$14.42
-54.30% from high
52W low
$4.46
21% of range
Market cap
$352.3M
EPS
$-0.6265
Beta
0.63
Shares out
53.2M
Volume
58K
0.25× rel vol
Avg volume
227.6K
VWAP
$6.60
Price history computed in-house
1W
+6.81%
1M
+1.07%
3M
+10.02%
1Y
+47.76%
YTD
-38.35%
SMA 50 $6.38 · above
SMA 200 $6.54 · above
52W position 21%

CV overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading CV Form 4 filings
Public disclosures

Congress activity in CV

No receipt-qualified filings found.

Federal contracts

CV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CV in this window.
Lobbying spend

CV lobbying filings, year to date.

Registered lobbying filings matched to CapsoVision Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CV in this window.
Loading news for CV
Analyst ratings
Sovereign unlock shows live analyst consensus for CV.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.